Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Division of Dermatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
PLoS One. 2019 Jan 16;14(1):e0210076. doi: 10.1371/journal.pone.0210076. eCollection 2019.
Correlation between severity of psoriasis and psoriatic arthritis (PsA) is inconsistent. Also, human leukocyte antigen (HLA)-Cw6 was found to be underrepresented in severe psoriasis who failed conventional systemic therapies, but the effect of HLA polymorphism on PsA severity needs to be confirmed.
To describe the severity of psoriasis, demographic features and HLA polymorphism among Chinese patients with active peripheral type PsA who had inadequate response to conventional disease-modifying antirheumatic drugs.
We included all patients with PsA who had at least 3 tender and swollen peripheral joints despite at least two conventional non-biologic treatments in our clinic. Demographic results were compared with global pivotal studies of biologics for PsA. HLA-Cw and HLA-DRB1 genotyping was also analyzed.
We identified 60 patients who met our inclusion criteria. The male to female ratio was 1.31:1. The majority of patients presented with psoriasis first (81.7%). The mean interval between psoriasis and PsA was 7.2 ± 8.1 years (mean ± SD). The baseline number of tender and swollen joints was 14.9 ± 10.7 and 11.3 ±10.2, respectively. In total, 41.7% subjects had more than 3% body surface area involvement of psoriasis. Genotyping of HLA-Cw and HLA-DRB1 was performed in 47 subjects. HLA-Cw0702 was the most frequent allele (29.8%), followed by HLA-Cw01 (26.6%). The frequency of HLA-Cw0602 allele was similar to normal population. The most frequent HLA-DRB1 allele was HLA-DRB104 (20.2%), followed by HLA-DRB108 (16.0%). No cases carrying HLA-DRB113 were detected.
Compared with Western population, our patients had less psoriasis and PsA burden. The frequencies of HLA-Cw06, HLA-Cw12, and HLA-DRB107 were not increased. In contrast, HLA-Cw0702 and HLA-DRB1*08 allele frequencies were increased compared with psoriasis patients and normal population in Taiwan. Future studies are still needed to characterize the demographic and genetic features of high need PsA patients.
银屑病严重程度与银屑病关节炎(PsA)之间的相关性并不一致。此外,在对常规系统治疗反应不佳的重度银屑病患者中,发现人类白细胞抗原(HLA)-Cw6 表达不足,但 HLA 多态性对 PsA 严重程度的影响仍需确认。
描述中国活动性外周型 PsA 患者在常规疾病修饰抗风湿药物治疗反应不足时的银屑病严重程度、人口统计学特征和 HLA 多态性。
我们纳入了在我院就诊时至少有 3 个压痛和肿胀的外周关节且至少接受了 2 种常规非生物治疗的 PsA 患者。将人口统计学结果与生物制剂治疗 PsA 的全球关键性研究进行比较。还分析了 HLA-Cw 和 HLA-DRB1 基因分型。
我们确定了 60 名符合纳入标准的患者。男女比例为 1.31:1。大多数患者首先出现银屑病(81.7%)。银屑病和 PsA 之间的平均间隔时间为 7.2 ± 8.1 年(平均值 ± 标准差)。基线时压痛和肿胀关节的数量分别为 14.9 ± 10.7 和 11.3 ± 10.2。共有 41.7%的患者有超过 3%的银屑病体表面积受累。对 47 名患者进行了 HLA-Cw 和 HLA-DRB1 基因分型。最常见的等位基因为 HLA-Cw0702(29.8%),其次为 HLA-Cw01(26.6%)。HLA-Cw0602 等位基因的频率与正常人群相似。最常见的 HLA-DRB1 等位基因为 HLA-DRB104(20.2%),其次为 HLA-DRB108(16.0%)。未检测到携带 HLA-DRB113 的病例。
与西方人群相比,我们的患者银屑病和 PsA 负担较轻。HLA-Cw06、HLA-Cw12 和 HLA-DRB107 的频率没有增加。相反,与台湾的银屑病患者和正常人群相比,HLA-Cw0702 和 HLA-DRB1*08 等位基因的频率增加。仍需要进一步研究以明确高需求 PsA 患者的人口统计学和遗传学特征。